Pfizer CEO Bourla says company can shift operations from foreign sites to US manufacturing network to counter Trump's tariffs ...

Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

Share market today, March 4, 2025: With US President Donald Trump confirming on Monday that tariffs on Mexico and Canada ...

Big Pharma executives feel optimistic about their industry’s trajectory under a second Donald Trump presidency, with regulation rollbacks and other changes likely to boost bottom lines for drugmakers, ...

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Pfizer CEO Albert Bourla said on Monday that the drugmaker can shift manufacturing for the US market to its existing plants in the US, as the threat of tariffs puts a question mark over global supply ...

TD Cowen 45th Annual Health Care Conference March 3, 2025 10:30 AM ETCompany ParticipantsAlbert Bourla - Chairman and ...

The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on ...

If something happens, we will try to mitigate by transferring from manufacturing sites outside to manufacturing sites here' ...